Answers are grounded in this paper and cite their sources.
Cost-effectiveness analysis shows health gains and savings in diabetes remission through weight management intervention, suggesting a beneficial approach.
The costs involved in achieving remissions from type 2 diabetes with the Counterweight-Plus diet programme were offset within 5 years through reduced healthcare resource use. Though remission may ultimately relapse, sustained weight loss brings other longer term health gains. The intervention, even using one-to-one face-to-face contacts rather than remote delivery, which is increasingly adopted, generated both health gains and cost-savings compared with current best practice.
No takes yet. Share an insight, caveat, or question.
Davies et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: